MiMedx Group, Inc. is a placental biologics company. The Company is engaged in developing and distributing placental tissue allografts with patent-protected, processes for multiple sectors of healthcare. Its product portfolio categories include Wound Care Products, and Surgical and Other Products. Its Wound Care Products include EPIFIX, EPICORD and EPIEFFECT, which are all marketed for external use, such as in advanced wound care applications. Its Surgical and Other product offering includes AMNIOFIX, AMNIOCORD and AMNIOEFFECT, which are positioned for use in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. The Company's platform technologies include tissue allografts derived from the human placental membrane, tissue allografts derived from the human umbilical cord, and a particulate extracellular matrix derived from the human placental disc.
Símbolo de cotizaciónMDXG
Nombre de la empresaMiMedx Group Inc
Fecha de salida a bolsaAug 20, 2007
Director ejecutivoMr. Joseph H. (Joe) Capper
Número de empleados837
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 20
Dirección1775 W Oak Commons Court, Ne
CiudadMARIETTA
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal30062
Teléfono17706519100
Sitio Webhttps://mimedx.com/
Símbolo de cotizaciónMDXG
Fecha de salida a bolsaAug 20, 2007
Director ejecutivoMr. Joseph H. (Joe) Capper
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.

Sin datos